Penserra Capital Management LLC Astrazeneca PLC Transaction History
Penserra Capital Management LLC
- $5.61 Billion
- Q1 2025
A detailed history of Penserra Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Penserra Capital Management LLC holds 3,183 shares of AZN stock, worth $224,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,183
Previous 2,957
7.64%
Holding current value
$224,115
Previous $193,000
20.73%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.02 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.86 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.24 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.2 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $218B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...